National Institute for Health and Care Excellence

Spectra Optia for automatic red blood cell exchange in people with sickle cell disease

The company identified 7 studies from the clinical evidence search which incorporated an economic analysis. However, it was unable to draw any firm conclusions from these studies. The external ...
Business Wire

Terumo BCT Enters Agreement with Kaneka Corporation

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has entered into a business relationship with Kaneka, a global leader ...
technologynetworks

Terumo Blood and Cell Technologies Supports Expanded Access to Rare Disease Therapies in Latin America

In a significant step toward expanding treatment access for people with rare and chronic diseases in Latin America (LATAM), Terumo Blood and Cell Technologies (Terumo BCT), announced that its Spectra ...
National Institute for Health and Care Excellence

Spectra Optia for automatic red blood cell exchange in people with sickle cell disease

The Spectra Optia Apheresis System (Terumo BCT) is an apheresis and cell collection platform which can be used in the treatment of sickle cell disease. The purpose of this evaluation is to assess the ...